Spinoff Breathe Biologics to Lead TSOI’s Stem Cell Therapy Research

Therapeutic Solutions International (TSOI) has launched a pharmaceutical spin-off — Breathe Biologics — that will take the lead in developing and marketing therapies for chronic obstructive pulmonary disease (COPD), including JadiCell, its investigational stem cell therapy. TSOI has licensed to Breathe Biologics the investigational new drug (IND) application for…

Immune-suppressing Cells Boost JadiCells’ Therapeutic Effects in Mice

Treatment with immune-suppressing myeloid-derived suppressor cells alongside JadiCell — an investigational stem cell therapy from Therapeutic Solutions International (TSOI) for chronic obstructive pulmonary disease (COPD) — led to more significant reductions in lung damage in mice compared with either treatment alone. Using them together also enhanced pulmonary regeneration…

TSOI Seeks FDA OK to Launch Phase 1 Trial of JadiCell

Therapeutic Solutions International (TSOI) is seeking permission from the U.S. Food and Drug Administration (FDA) to conduct a Phase 1 study of JadiCell, its investigational stem cell therapy, in 10 people with advanced chronic obstructive pulmonary disease (COPD). The request — submitted in the form of an investigational…

Stem Cell Therapy Improves Lung Inflammation, Tissue Damage in Mice

Stem cell therapy reduced lung inflammation and improved lung damage repair in a mouse model of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. The findings were presented at the Lung Science Conference recently in Estoril, Portugal. Mesenchymal stem cell (MSC) therapy uses stem cells (multipotent cells that can differentiate into a variety…

COPD Improves with Stem Cell Therapy

Four Lung Institute facilities in Tampa, Scottsdale, Nashville and Pittsburg, treat restrictive and obstructive lung diseases using stem cells from the patient’s own body. Gary V., a patient, has seen his quality of life improve since he receive stem cell therapy for chronic obstructive pulmonary disease (COPD). For Gary, “improvement” is…